Short Interest in Revelation Biosciences, Inc. (NASDAQ:REVBW) Decreases By 35.0%

Revelation Biosciences, Inc. (NASDAQ:REVBW) was the target of a large drop in short interest in the month of April. As of April 30th, there was short interest totaling 48,365 shares, a drop of 35.0% from the April 15th total of 74,414 shares. Based on an average daily trading volume, of 22,278 shares, the days-to-cover ratio is presently 2.2 days.

Revelation Biosciences Stock Performance

Shares of REVBW traded down $0.00 during midday trading on Monday, hitting $0.01. The company had a trading volume of 367,549 shares, compared to its average volume of 93,847. Revelation Biosciences has a 1 year low of $0.01 and a 1 year high of $0.04. The company’s 50-day simple moving average is $0.01 and its 200-day simple moving average is $0.01.

About Revelation Biosciences

Revelation Biosciences, Inc (NASDAQ: REVBW) is a clinical-stage molecular diagnostics company focused on the rapid detection of life-threatening bacterial infections. The company leverages next-generation sequencing (NGS) to analyze cell-free microbial DNA in patient blood samples, with an emphasis on early identification of pathogens in bloodstream infections and hospital-acquired pneumonia. By targeting critically ill patients, Revelation Biosciences aims to shorten time to diagnosis and guide more effective antimicrobial therapy.

The company’s technology platform integrates high-throughput DNA sequencing with proprietary bioinformatics algorithms to differentiate pathogenic microbes from background microbial DNA.